Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Rhythm Pharmaceuticals (RYTM) Preferred Shares Issued (2017 - 2019)

Rhythm Pharmaceuticals (RYTM) has disclosed Preferred Shares Issued for 2 consecutive years, with $263000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $263000.0 in Q3 2019 year-over-year; TTM through Dec 2024 was $263000.0, a N/A change, with the full-year FY2024 number at $138.8 million, changed N/A from a year prior.
  • Preferred Shares Issued was $263000.0 for Q3 2019 at Rhythm Pharmaceuticals, down from $295000.0 in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $20.5 million in Q3 2017 to a low of $263000.0 in Q3 2019.